CLYM: Climb Bio Inc O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati
Climb Bio Inc (CLYM) immunoterapiyalarni ishlab chiqishga e'tibor qaratadi, bu esa savdolarning yo'qligi sababli binar xatarlarni yuzaga keltiradi. PEG koeffitsiyenti trayektoriyasi lokal dinamikani namoyish etadi, bunda 0.00 qiymati bazaviy baholash ko'rsatkichi bo'lib xizmat qiladi. Yuqori R&D xarajatlari va patentlar raqobatchilarning kirishini cheklaydi. Shu bilan birga, tizimli qizil tosh (lupus) davolash uchun noyob dori vositasi elastik bo'lmagan talab sharoitida kompaniyaga sezilarli narx belgilash imkoniyatini beradi.
Climb Bio Inc (CLYM) kompaniyasi koʻrsatkichlari kesimi va tahlili
- aksiya narxi va baholash bo'yicha konsensus prognoz:
- bozor kapitallashuvi haqida ma'lumot:
- kompaniyaning balans qiymati tafsilotlari:
- emitentning kredit yuki va likvidlik ko'rsatkichlari:
Umumiy qarzning kapitalga nisbati Climb Bio Inc|CLYM - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati ko'rsatkichi climbbio.com|CLYM - Kompaniyaning jamlangan qarzlari|Balans qiymatiga qarzlar Climb Bio Inc|CLYM - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli majburiyatlari Climb Bio|Tezkor likvidlik climbbio.com
- biznes foydasi va investitsiya koeffitsiyentlari ma'lumotlari:
CLYM - Sof foyda|Kompaniya foydasi prognozi Climb Bio Inc|CLYM - Narxning foydaga nisbati|Prognoz qilingan narxning foydaga nisbati Climb Bio, Inc|CLYM - PEG multiplikatori|Korxona qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati Climb Bio Inc|CLYM - Eskirish chegirilmasdan oldingi operatsion foyda|Sirpanuvchi yil uchun bir aksiya uchun foyda Climb Bio|CLYM - Bir aksiya uchun sof foyda (EPS TTM)|So'nggi o'n ikki oy davomida bir aksiya uchun foydaning yillik o'sishi climbbio.com|CLYM - Joriy yilda foyda o'sishi|Keyingi yil uchun bir aksiya uchun foyda o'sishining konsensus prognozi Climb Bio Inc
Kompaniyaning umumiy tahlili:CLYM - Climb Bio Inc.
Ushbu ko'rsatkich foydaning bozor qiymatini uning o'sish sur'ati bilan bog'laydi, bunda birdan past qiymat aktivning kengayishiga nisbatan qadrsizlanganligini anglatadi. PEG koeffitsiyentini tahlil qilish orqali Climb Bio Inc (CLYM) investori immunologik molekulalar bo'yicha yuqori R&D xarajatlari xavfini kapitalizatsiya salohiyati bilan muvozanatga keltirishi, shu bilan birga mavjud naqd pul rezervlaridan foydalanish samaradorligini baholashi mumkin.
Raqobatdosh kompaniyalar
ARGX (argenx N.V.) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori BNTX (BioNTech Group)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Abivax (ABVX)|ADMA - Narxning foydaga va o‘sish sur’atiga nisbati|protagonist-inc.com (PTGX) - Narx-foyda va o‘sish multiplikatori|Immunovant (IMVT) - Narxning foydaga va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori Kiniksa Pharmaceuticals, Ltd.|Narx-foyda va o‘sish multiplikatori GRFS|PEG multiplikatori Adaptive Biotechnologies Inc.|Narxning foydaga va o‘sish sur’atiga nisbati Celldex Therapeutics (CLDX)|auriniapharma.com - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|PEG multiplikatori BCRX (BioCryst Pharmaceuticals)|Vera Therapeutics Inc (VERA) - O‘sish sur’atiga tuzatilgan narx-foyda|Dianthus Pharma - PEG multiplikatori|Pharvaris Pharma (PHVS) - Narx-foyda va o‘sish multiplikatori|abcellera.com (ABCL) - Narxning foydaga va o‘sish sur’atiga nisbati|TRML (tourmalinebio.com) - Narxning foydaga va o‘sish sur’atiga nisbati|PGEN (Precigen) - PEG multiplikatori|Pharming Group NV (PHAR) - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati Nektar (NKTR)|Narx-foyda va o‘sish multiplikatori Upstream Pharma UPB|PEG multiplikatori ZBIO (Zenas Biopharma Inc)|immunome.com - Narxning foydaga va o‘sish sur’atiga nisbati|GOSS: Narx-foyda va o‘sish multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti KALV (KalVista Pharma)|SEPN: PEG multiplikatori|PVLA (Pieris Corp) - Narxning foydaga va o‘sish sur’atiga nisbati|SVRA (Savara Inc.) - PEG multiplikatori|rigel.com (RIGL) - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati AnaptysBio (ANAB)|ATXS - O‘sish sur’atiga tuzatilgan narx-foyda|enGene Bio - Narx-foyda va o‘sish multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti RAPT|Aerovate - PEG multiplikatori|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati aclaristx.com ACRS|Kyverna Therapeutics, Inc. (KYTX) - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sishni hisobga olgan narx-foyda koeffitsiyenti TLSA|CABA (Cabaletta Bio, Inc) - PEG multiplikatori|Narx-foyda va o‘sish multiplikatori Ventyx Biosciences, Inc (VTYX)|PEG multiplikatori THTX|Narx-foyda va o‘sish multiplikatori avalotx.com AVTX|Narxning foydaga va o‘sish sur’atiga nisbati Eledon Pharmaceuticals, Inc. ELDN|Agenus, Inc. - Narxning foydaga va o‘sish sur’atiga nisbati|ZURA: Narx-foyda va o‘sish multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda aTyr Pharmaceuticals|adagene.com (ADAG) - Narxning foydaga va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori Ikena Oncology|Narxning foydaga va o‘sish sur’atiga nisbati Shattuck Labs Inc|Equillium Bio - Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|PEG multiplikatori CNTB|IMUX (immunic-therapeutics.com) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori ATRA (Atara Bio)|PEG multiplikatori InflaRx NV IFRX|XFOR - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti ACET (Adicet Bio)|celularity.com (CELU) - Narxning foydaga va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori INmune Bio Corporation|BRNS (Barinthus Biotherapeutics) - PEG multiplikatori|PEG multiplikatori kezarlifesciences.com|Narx-foyda va o‘sish multiplikatori SABS (SAB Biotherapeutics, Inc.)|AKTX (Akari Therapeutics PLC) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori ENLV (Enlivex Therapeutics Ltd.)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Q32 Bio Inc (QTTB)|GOVX - Narxning foydaga va o‘sish sur’atiga nisbati|edesabiotech.com (EDSA) - Narx-foyda va o‘sish multiplikatori|iBio (IBIO) - Narxning foydaga va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori Carisma Therapeutics Inc.|Narx-foyda va o‘sish multiplikatori XTLB|PEG multiplikatori Bolt Bio|Narxning foydaga va o‘sish sur’atiga nisbati HCW Biologics Inc. (HCWB)|aptevotherapeutics.com - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|PEG multiplikatori AIM (AIM ImmunoTech)|Aditxt Inc. (ADTX) - O‘sish sur’atiga tuzatilgan narx-foyda|GRI Bio Corp - PEG multiplikatori|XORTX Corp (XRTX) - Narx-foyda va o‘sish multiplikatori|Vyome Holdings Inc (HIND) - Narxning foydaga va o‘sish sur’atiga nisbati|REVB (revbiosciences.com) - Narxning foydaga va o‘sish sur’atiga nisbati|INDP (Indaptus Therapeutics, Inc.) - PEG multiplikatori|Scinai Immunotherapeutics Ltd (SCNI) - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati CalciMedica, Inc. (CALI)|Narx-foyda va o‘sish multiplikatori affimed.com AFMD|PEG multiplikatori ALLK (Allakos)|HOOKIPA Pharma, Inc. - Narxning foydaga va o‘sish sur’atiga nisbati|IGMS: Narx-foyda va o‘sish multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti ITOS (iTeos Therapeutics Inc)|OCEA: PEG multiplikatori|TCBP (TC BioPharm Ltd) - Narxning foydaga va o‘sish sur’atiga nisbati|THRD (Third Harmonic Bio) - PEG multiplikatori
